R01 CA176624/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2014	5
2015	5
2016	3
2017	6
2018	8
2019	5
2021	1
2024	0

1

Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy.

Wei J, Long L, Zheng W, Dhungana Y, Lim SA, Guy C, Wang Y, Wang YD, Qian C, Xu B, Kc A, Saravia J, Huang H, Yu J, Doench JG, Geiger TL, Chi H. Wei J, et al. Nature. 2019 Dec;576(7787):471-476. doi: 10.1038/s41586-019-1821-z. Epub 2019 Dec 11. Nature. 2019. PMID: 31827283 Free PMC article.

2

In vivo CRISPR screening reveals nutrient signaling processes underpinning CD8⁺ T cell fate decisions.

Huang H, Zhou P, Wei J, Long L, Shi H, Dhungana Y, Chapman NM, Fu G, Saravia J, Raynor JL, Liu S, Palacios G, Wang YD, Qian C, Yu J, Chi H. Huang H, et al. Cell. 2021 Mar 4;184(5):1245-1261.e21. doi: 10.1016/j.cell.2021.02.021. Epub 2021 Feb 25. Cell. 2021. PMID: 33636132 Free PMC article.

3

Integrative Proteomics and Phosphoproteomics Profiling Reveals Dynamic Signaling Networks and Bioenergetics Pathways Underlying T Cell Activation.

Tan H, Yang K, Li Y, Shaw TI, Wang Y, Blanco DB, Wang X, Cho JH, Wang H, Rankin S, Guy C, Peng J, Chi H. Tan H, et al. Immunity. 2017 Mar 21;46(3):488-503. doi: 10.1016/j.immuni.2017.02.010. Epub 2017 Mar 9. Immunity. 2017. PMID: 28285833 Free PMC article.

4

Metabolic control of regulatory T cell development and function.

Zeng H, Chi H. Zeng H, et al. Trends Immunol. 2015 Jan;36(1):3-12. doi: 10.1016/j.it.2014.08.003. Epub 2014 Sep 20. Trends Immunol. 2015. PMID: 25248463 Free PMC article. Review.

5

mTOR signaling, Tregs and immune modulation.

Chapman NM, Chi H. Chapman NM, et al. Immunotherapy. 2014;6(12):1295-311. doi: 10.2217/imt.14.84. Immunotherapy. 2014. PMID: 25524385 Free PMC article. Review.

6

mTOR Links Environmental Signals to T Cell Fate Decisions.

Chapman NM, Chi H. Chapman NM, et al. Front Immunol. 2015 Jan 20;5:686. doi: 10.3389/fimmu.2014.00686. eCollection 2014. Front Immunol. 2015. PMID: 25653651 Free PMC article. Review.

7

mTOR and metabolic regulation of conventional and regulatory T cells.

Liu C, Chapman NM, Karmaus PW, Zeng H, Chi H. Liu C, et al. J Leukoc Biol. 2015 May;97(5):837-847. doi: 10.1189/jlb.2RI0814-408R. Epub 2015 Feb 24. J Leukoc Biol. 2015. PMID: 25714803 Free PMC article. Review.

8

Emerging Roles of Cellular Metabolism in Regulating Dendritic Cell Subsets and Function.

Du X, Chapman NM, Chi H. Du X, et al. Front Cell Dev Biol. 2018 Nov 13;6:152. doi: 10.3389/fcell.2018.00152. eCollection 2018. Front Cell Dev Biol. 2018. PMID: 30483503 Free PMC article. Review.

9

mTOR signaling in the differentiation and function of regulatory and effector T cells.

Zeng H, Chi H. Zeng H, et al. Curr Opin Immunol. 2017 Jun;46:103-111. doi: 10.1016/j.coi.2017.04.005. Epub 2017 May 20. Curr Opin Immunol. 2017. PMID: 28535458 Free PMC article. Review.

10

LKB1 orchestrates dendritic cell metabolic quiescence and anti-tumor immunity.

Wang Y, Du X, Wei J, Long L, Tan H, Guy C, Dhungana Y, Qian C, Neale G, Fu YX, Yu J, Peng J, Chi H. Wang Y, et al. Cell Res. 2019 May;29(5):391-405. doi: 10.1038/s41422-019-0157-4. Epub 2019 Mar 25. Cell Res. 2019. PMID: 30911060 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Results by year